Advertisement
Home Blog Page 3621

May 2015 Briefing – Neurology

0
Here are what the editors at HealthDay consider to be the most important developments in Neurology for May 2015. This roundup includes the latest...

May 2015 Briefing – Infectious Disease

0
Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for May 2015. This roundup includes the...

May 2015 Briefing – HIV & AIDS

0
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for May 2015. This roundup includes...

May 2015 Briefing – Gastroenterology

0
Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for May 2015. This roundup includes the latest...

May 2015 Briefing – Family Practice

0
Here are what the editors at HealthDay consider to be the most important developments in Family Practice for May 2015. This roundup includes the...

May 2015 Briefing – Diabetes & Endocrinology

0
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for May 2015. This roundup includes...

May 2015 Briefing – Dermatology

0
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for May 2015. This roundup includes the latest...

May 2015 Briefing – Cardiology

0
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for May 2015. This roundup includes the latest...

May 2015 Briefing – Allergy

0
Here are what the editors at HealthDay consider to be the most important developments in Allergy for May 2015. This roundup includes the latest...
An immune checkpoint inhibitor

ASCO: PD-1 Immunotherapy Benefits Patients With NSCLC

0
Fewer side effects, longer survival for nivolumab versus docetaxel